Hong Qi Zhang

Prof. Hong Qi Zhang


Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 February 2015 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
CLChao Liang
Chao Liang
BGBaosheng Guo
Baosheng Guo
HWHeng Wu
Heng Wu
NSNingsheng Shao
Ningsheng Shao
DLDefang Li
Defang Li
GZGe Zhang
Ge Zhang

1 January 2013 in Autophagy
Verified
Journal Article
Open access
PDF file
JSJu-Xian Song
Ju-Xian Song
JLJiahong Lu
Jiahong Lu
LLLiang-Feng Liu
Liang-Feng Liu
LCLei-Lei Chen
Lei-Lei Chen
SDSiva Sundara Kumar Durairajan
Siva Sundara Kumar Durairajan
MLMin LI
Min LI
SNCA/α-synuclein and its rare mutations are considered as the culprit proteins in Parkinson disease (PD). Wild-type (WT) SNCA has been shown to impair macroautophagy in mammalian cells and in transgenic mice. In this study, we monitored the dynamic changes in autophagy process and confirmed that overexpression of both WT and SNCAA53T inhibits autophagy in PC12 cells in a time-dependent manner. Furthermore, we showed that SNCA binds to both cytosolic and nuclear high mobility group box 1 (HMGB1), impairs the cytosolic translocation of HMGB1, blocks HMGB1-BECN1 binding, and strengthens BECN1-BCL2 binding. Deregulation of these molecular events by SNCA overexpression leads to autophagy inhibition. Overexpression of BECN1 restores autophagy and promotes the clearance of SNCA. siRNA knockdown of Hmgb1 inhibits basal autophagy and abolishes the inhibitory effect of SNCA on autophagy while overexpression of HMGB1 restores autophagy. Corynoxine B, a natural autophagy inducer, restores the deficient cytosolic translocation of HMGB1 and autophagy in cells overexpressing SNCA, which may be attributed to its ability to block SNCA-HMGB1 interaction. Based on these findings, we propose that SNCA-induced impairment of autophagy occurs, in part, through HMGB1, which may provide a potential therapeutic target for PD.

1 May 2016 in Nanomedicine: Nanotechnology, Biology and Medicine
Verified
Journal Article
Closed access
XZXue Zhang
Xue Zhang
HNHuei Leng Helena Ng
Huei Leng Helena Ng
ALAiping Lu
Aiping Lu
CLCongcong Lin
Congcong Lin
LZLimin Zhou
Limin Zhou
HZHong Qi Zhang
Hong Qi Zhang

1 June 2015 in Biomaterials
Verified
Journal Article
Closed access
JLJin Liu
Jin Liu
LDLei Dang
Lei Dang
DLDefang Li
Defang Li
CLChao Liang
Chao Liang
XHXiaojuan He
Xiaojuan He
GZGe Zhang
Ge Zhang

1 June 2007 in Brain Research
Verified
Journal Article
Closed access
ECElaine K.Y. Chung
Elaine K.Y. Chung
XZXiaoJun Zhang
XiaoJun Zhang
ZLZhi Li
Zhi Li
HZHong Qi Zhang
Hong Qi Zhang
HXHongXi Xu
HongXi Xu
ZBZhaoXiang Bian
ZhaoXiang Bian

1 November 2009 in Pharmacology Biochemistry and Behavior
Verified
Journal Article
Closed access
XZXiao-Jun Zhang
Xiao-Jun Zhang
HCHong-Li Chen
Hong-Li Chen
ZLZhi Li
Zhi Li
HZHong Qi Zhang
Hong Qi Zhang
HXHong-Xi Xu
Hong-Xi Xu
ZBZhao-Xiang Bian
Zhao-Xiang Bian